Thesis (M.S.)--West Virginia University, 2008. / Title from document title page. Document formatted into pages; contains ix, 128 p. : ill. (some col.). Includes abstract. Includes bibliographical references (p. 118-127).

Thesis (Ph. D.)--University of Texas at Austin, 2008. / Vita. Includes bibliographical references.

Thesis (M.S.)--West Virginia University, 2005. / Title from document title page. Document formatted into pages; contains vi, 90 p. : ill. (some col.). Includes abstract. Includes bibliographical references (p. 79-90).

Thesis (M.Phil.)--Hong Kong University of Science and Technology, 2007. / On t.p. "2̳+̳" is superscript. Includes bibliographical references (leaves 137-155). Also available in electronic version.

Emerging evidence indicates that the dysregulation of protein ubiquitination plays a crucial role in aging-associated diseases. Smad-dependent canonical BMP signaling pathway is indispensable for osteoblastic bone formation, which could be disrupted by the ubiquitination and subsequent proteasomal degradation of Smad1/5, the key molecules for BMP signaling transduction. However, whether the dysregulation of Smad1/5 ubiquitination and disrupted BMP signaling pathway are responsible for the age-related bone formation reduction is still underexplored. Casein kinase-2 interacting protein-1 (CKIP-1), also known as Pleckstrin homology domain-containing family O member 1 (PLEKHO1), is a previously identified ubiquitination-related molecule that could specifically target the linker region between the WW domains of Smurf1 to promote the ubiquitination of Smad1/5. Here, we found an age-related increase in the expression of CKIP-1 in bone specimens from either fractured patients or aging rodents, which was associated with the age-related reduction in Smad-dependent BMP signaling and bone formation. By genetic approach, we demonstrated that loss of Ckip-1 in osteoblasts could promote the Smad-dependent BMP signaling and alleviated the age-related bone formation reduction. In addition, osteoblast-specific Smad1 overexpression had beneficial effect on bone formation during aging, which could be counteracted after overexpressing Ckip-1 within osteoblasts. By pharmacological approach, we showed that osteoblast-targeted CKIP-1 siRNA treatment could enhance Smad-dependent BMP signaling and promote bone formation in aging rodents. Taken together, it suggests that the increased CKIP-1 could suppress Smad-dependent BMP signaling to inhibit bone formation during aging, indicating the translational potential of targeting CKIP-1 in osteoblast as a novel bone anabolic strategy for reversing established osteoporosis during aging.

Die heterotetramere Proteinkinase CK2 nimmt aufgrund der großen Anzahl und Diversität ihrer Substrate, sowie aufgrund ihrer Eigenschaft Signalwege miteinander zu vernetzen eine Sonderstellung innerhalb der Kinasen ein. CK2 beeinflusst Proliferation, Differenzierung und Apoptose, Prozesse an denen auch Polyamine und der MAPK-Signalweg beteiligt sind. Eine vor kurzem durchgeführte Arbeit beschreibt die Bindung von CK2 an das Gerüstprotein KSR und die Verstärkung des MAPK-Signalwegs durch Phosphorylierung von Raf-Proteinen in Vertebraten. In dieser Arbeit konnte gezeigt werden, dass CK2 auch in Drosophila mit KSR interagiert und das einzige in Drosophila vorhandene Raf-Potein (DRaf) in vitro phosphoryliert. Im Gegensatz zur Phosphorylierung der humanen B-Raf und C-Raf Proteine an Serin 446 bzw. Serin 338 innerhalb der „negative charge regulatory region“ (N-Region), führten Kinasereaktionen und Massenspektrometrische Untersuchungen zur Identifizierung von Serin 11 als CK2 Phosphorylierungsstelle in DRaf, während ein zu Serin 446 in B-Raf äquivalentes Serin in der N-Region in Drosophila nicht durch CK2 phosphoryliert wird. Durch Überexpression von DRaf sowie von zwei DRaf-Varianten bei denen Serin 11 durch Alanin oder Aspartat substituiert wurde (DRafS11A und DRafS11D) konnte in Zellkulturexperimenten gezeigt werden, dass die Ladung an der Aminosäureposition 11 die Funktion von DRaf beeinflusst, wobei eine negative Ladung an dieser Stelle zur Phosphorylierung und Aktivierung der Effektorkinase Erk führt. Die Phosphorylierung durch CK2 ist unabhängig von regulatorischen Botenstoffen ("second messengers"), wird aber durch Bindung von Polyaminen moduliert. Intrazelluläre Polyamine entstammen zum grossen Teil dem zellulären Aminosäurekatabolismus und beeinflussen die Phosphorylierung von DRaf durch CK2 in vitro, wobei Spermin ein effizienter Inhibitor der Reaktion ist, während die Effekte von Putrescin und Spermidin gering sind. Auch in Drosophila Schneider S2 Zellen und in adulten weiblichen Fliegen hat Spermin einen inhibitorischen, CK2-abhängigen Effekt auf die Aktivierung von Erk. Ausserdem konnte gezeigt werden, dass Putrescin und Spermidin in der Lage sind die Aktivierung von Erk, im Vergleich zu Zellen die nur mit Spermin behandelt wurden, zu erhöhen. Das spricht dafür, dass die Phosphorylierung von DRaf und die davon abhängige Aktivierung von Erk durch CK2 von der Menge und Relation der verschiedenen Polyamine zueinander abhängt. Die Ergebnisse dieser Arbeit lassen den Schluss zu, dass der Polyaminmetabolismus über CK2 mit dem MAPK-Signalweg verknüpft ist. Nachdem Polyamine durch Aminosäurekatabolismus enstehen, kann auf diese Weise der MAPK-Signalweg in Abhängigkeit der Verfügbarkeit zellulärer Aminosäuren reguliert werden. Vorversuche zeigten eine Beeinflussung von Proliferation und Apoptose durch CK2 und Polyamine. Weitere Untersuchungen sind aber nötig um spezifische Einflüsse von Polyaminen und CK2 auf zelluläre Prozesse wie Proliferation, Differenzierung und Apoptose aufzudecken. / Because of its high number and diversity of substrates, as well as its ability to cross-link signalling pathways, the heterotetrameric protein kinase CK2 has an exceptional position within kinases. CK2 influences proliferation, differentiation and apoptosis, processes in which also polyamines and the MAPK-signalling pathway are involved. A recent publication delineates binding of CK2 to the scaffold protein KSR and the enhancement of the MAPK-signalling pathway by phosphorylation of Raf-proteins in vertebrates. In my thesis I could show that CK2 also interacts with KSR in Drosophila and phosphorylates the only existing Raf protein in Drosophila (DRaf) in vitro. In contrast to the phosphorylation of human B-Raf- and C-Raf-proteins on serine 446 respectively serine 338 within the "negative charge regulatory region" (N-region), kinase reactions and mass spectrometric analyses led to the identification of serine 11 as phosphorylation site in DRaf, whereas a serine in the N-region, which corresponds to serine 446 of B-Raf, is not phosphorylated by CK2 in Drosophila. In cell culture experiments overexpression of DRaf and two DRaf-variants, in which serine 11 was substituted by alanine or aspartate (DRafS11A and DRafS11D), revealed the charge at amino acid position 11 to affect the function of DRaf, with a negative charge leading to phosphorylation and activation of the effector kinase Erk. Phosphorylation by CK2 is independent of second messengers, whereas it is modified by binding of polyamines. Intracellular polyamines mainly derive from cellular amino acid catabolism and modulate the phosphorylation of DRaf by CK2 in vitro with spermine being an efficient inhibitor of the reaction, whereas the effects of putrescine and spermidine are minor. In Drosophila Schneider S2 cells and adult flies spermine inhibits the activation of Erk in a CK2-dependent way. Furthermore administration of putrescine and spermidine in combination with spermine leads to enhanced Erk activation in cells compared to cells that are treated with spermine. These results suggest that phosphorylation of DRaf and the subsequent activation of Erk by CK2 are dependent on the amount and relative concentrations of polyamines. Altogether the results of this work demonstrate a role for CK2 in linking polyamine metabolism to the MAPK-signalling pathway. Since polyamines derive from amino acid catabolism, the MAPK-signalling pathway can be regulated dependent on the availability of cellular amino acids. Preliminary experiments point to CK2- and polyamine-dependent effects on proliferation and apoptosis. Further investigations are necessary to reveal specific effects of polyamines and CK2 on cellular processes like proliferation, differentiation and apoptosis.

Protein kinase CK2 phosphorylates wheat eIF2, eIF3, eIF4B, eIF5 and three 60S ribosomal proteins. The substrate specificity of CK2[alpha] toward various plant initiation factor substrates was altered in vitro through holoenzyme formation in the presence of regulatory [beta]-subunits. This presents a potential mechanism through which the differential expression and sub-cellular distribution of CK2 [beta]-subunits could regulate phosphorylation of various CK2 substrates in plants. Our analysis of initiation factor phosphopeptides produced by in vitro phosphorylation identified 20 CK2 phosphorylation sites in eIF2[alpha], eIF2[beta], eIF3c, eIF4B, and eIF5. Native wheat eIF5 was prepared in the presence of phosphatase inhibitors and analyzed by mass spectrometry. Native wheat eIF5 was determined to be a phosphoprotein containing at least 3 phosphorylation sites. The C-terminal CK2 site (S451) of native eIF5 was completely phosphorylated, and tryptic fragments containing the other in vitro CK2 two sites (S209, T240) also appear to be partially phosphorylated. Many of the CK2 phosphorylation sites identified are in conserved binding domains of the yeast multifactor complex (eIF1/eIF3/eIF5/eIF2/GTP/Met-tRNAi[superscript Met). This observation lead to the hypothesis that CK2 phosphorylation may regulate the formation of plant multifactor complexes. The results presented here suggest that plant initiation factors are capable of forming complexes similar to those previously reported in yeast. The in vitro interaction of initiation factors within these complexes appears to be enhanced by phosphorylation of eIF2, eIF3c, and eIF5 by CK2. Site-directed mutagenesis of eIF5 to remove CK2 phosphorylation sites not only prevents the CK2 mediated increase in interaction with eIF1, but also resulted in reduced stimulation of translation initiation in vitro. / text

Histone deacetylases (HDAC) 1 and 2 play crucial role in chromatin remodeling and gene expression regimes, as part of multiprotein corepressor complexes. Protein kinase CK2-driven phosphorylation of HDAC1 and 2 regulates their catalytic activities and is required to form the corepressor complexes. Phosphorylation-mediated differential distributions of HDAC1 and 2 complexes in regulatory and coding regions of transcribed genes catalyze the dynamic protein acetylation of histones and other proteins, thereby influence gene expression. During mitosis, highly phosphorylated HDAC1 and 2 heterodimers dissociate and displace from mitotic chromosomes. Our goal was to identify the kinase involved in mitotic phosphorylation of HDAC1 and 2. We postulated that CK2-mediated increased phosphorylation of HDAC1 and 2 leads to dissociation of the heterodimers, and, the mitotic chromosomal exclusions of HDAC1 and 2 are largely due to the displacement of HDAC-associated proteins and transcription factors, which recruit HDACs, from chromosomes during mitosis. We further explored the role of un- or monomodified HDAC1 and 2 complexes in immediate-early genes (IEGs), FOSL1 (FOS-like antigen-1) and MCL1 (Myeloid cell leukemia-1), regulation. Dynamic histone acetylation is an important regulator of these genes that are overexpressed in a number of diseases and cancers. We hypothesized that transcription dependent recruitment of HDAC1 and 2 complexes over the gene body regions plays a regulatory role in transcription and splicing regulation of these genes. We present evidence that CK2-catalyzed increased phosphorylation of HDAC1 and 2 regulates the formation of distinct corepressor complexes containing either HDAC1 or HDAC2 homodimers during mitosis, which might target cellular factors. Furthermore, the exclusion of HDAC-recruiting proteins is the major factor for their displacement from mitotic chromosomes. We further demonstrated that un- or monophosphorylated HDAC1 and 2 are associated with gene body of FOSL1 in a transcription dependent manner. However, HDAC inhibitors prevented FOSL1 activation independently of the nucleosome response pathway, which is required for IEG induction. Interestingly, our mass spectrometry results revealed that HDAC1 and 2 interact with a number of splicing proteins, in particular, with serine/arginine-rich splicing factor 1 (SRSF1). HDAC1 and 2 are co-occupied with SRSF1 over gene body regions of FOSL1 and MCL1, regardless of underlying splicing mechanisms. Using siRNA-mediated knockdown approaches and HDAC inhibitors, we demonstrated that alternative splicing of MCL1 is regulated by RNA-directed localized changes in the histone acetylation levels at the alternative exon. The change in histone acetylation levels correlates with the increased transcription elongation and results in change in MCL1 splicing by exon skipping mechanism. Taken together, our results contribute to further understanding of how the multi-faceted HDAC1 and 2 complexes can be regulated and function in various processes, including, but not limited to, transcription regulation and alternative splicing. This can be an exciting area of future research for therapeutic interventions.

Histone deacetylases (HDAC) 1 and 2 play crucial role in chromatin remodeling and gene expression regimes, as part of multiprotein corepressor complexes. Protein kinase CK2-driven phosphorylation of HDAC1 and 2 regulates their catalytic activities and is required to form the corepressor complexes. Phosphorylation-mediated differential distributions of HDAC1 and 2 complexes in regulatory and coding regions of transcribed genes catalyze the dynamic protein acetylation of histones and other proteins, thereby influence gene expression. During mitosis, highly phosphorylated HDAC1 and 2 heterodimers dissociate and displace from mitotic chromosomes. Our goal was to identify the kinase involved in mitotic phosphorylation of HDAC1 and 2. We postulated that CK2-mediated increased phosphorylation of HDAC1 and 2 leads to dissociation of the heterodimers, and, the mitotic chromosomal exclusions of HDAC1 and 2 are largely due to the displacement of HDAC-associated proteins and transcription factors, which recruit HDACs, from chromosomes during mitosis. We further explored the role of un- or monomodified HDAC1 and 2 complexes in immediate-early genes (IEGs), FOSL1 (FOS-like antigen-1) and MCL1 (Myeloid cell leukemia-1), regulation. Dynamic histone acetylation is an important regulator of these genes that are overexpressed in a number of diseases and cancers. We hypothesized that transcription dependent recruitment of HDAC1 and 2 complexes over the gene body regions plays a regulatory role in transcription and splicing regulation of these genes. We present evidence that CK2-catalyzed increased phosphorylation of HDAC1 and 2 regulates the formation of distinct corepressor complexes containing either HDAC1 or HDAC2 homodimers during mitosis, which might target cellular factors. Furthermore, the exclusion of HDAC-recruiting proteins is the major factor for their displacement from mitotic chromosomes. We further demonstrated that un- or monophosphorylated HDAC1 and 2 are associated with gene body of FOSL1 in a transcription dependent manner. However, HDAC inhibitors prevented FOSL1 activation independently of the nucleosome response pathway, which is required for IEG induction. Interestingly, our mass spectrometry results revealed that HDAC1 and 2 interact with a number of splicing proteins, in particular, with serine/arginine-rich splicing factor 1 (SRSF1). HDAC1 and 2 are co-occupied with SRSF1 over gene body regions of FOSL1 and MCL1, regardless of underlying splicing mechanisms. Using siRNA-mediated knockdown approaches and HDAC inhibitors, we demonstrated that alternative splicing of MCL1 is regulated by RNA-directed localized changes in the histone acetylation levels at the alternative exon. The change in histone acetylation levels correlates with the increased transcription elongation and results in change in MCL1 splicing by exon skipping mechanism. Taken together, our results contribute to further understanding of how the multi-faceted HDAC1 and 2 complexes can be regulated and function in various processes, including, but not limited to, transcription regulation and alternative splicing. This can be an exciting area of future research for therapeutic interventions.

Thesis (Ph. D.)--West Virginia University, 2007. / Title from document title page. Document formatted into pages; contains vi, 130 p. : ill. (some col.). Includes abstract. Includes bibliographical references.